Cargando…
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study
BACKGROUND: An outbreak of COVID-19 in Iran has spread throughout the country. Identifying the epidemiological characteristics of this disease will help to make appropriate decisions and thus control the epidemic. The aim of this study was characterization of the epidemiological features of COVID-19...
Autores principales: | Nikpouraghdam, Mohamad, Jalali Farahani, Alireza, Alishiri, GholamHossein, Heydari, Soleyman, Ebrahimnia, Mehdi, Samadinia, Hossein, Sepandi, Mojtaba, Jafari, Nematollah Jonaidi, Izadi, Morteza, Qazvini, Ali, Dorostkar, Ruhollah, Tat, Mahdi, Shahriary, Alireza, Farnoosh, Gholamreza, Hosseini Zijoud, Seyed Reza, Taghdir, Maryam, Alimohamadi, Yousef, Abbaszadeh, Sepideh, Gouvarchin Ghaleh, Hadi Esmaeili, Bagheri, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172806/ https://www.ncbi.nlm.nih.gov/pubmed/32353762 http://dx.doi.org/10.1016/j.jcv.2020.104378 |
Ejemplares similares
-
Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment
por: Hosseini, Abdolkarim, et al.
Publicado: (2021) -
Are Iranian Sulfur Mustard Gas-Exposed Survivors More Vulnerable to SARS-CoV-2? Some Similarity in Their Pathogenesis
por: Farnoosh, Gholamreza, et al.
Publicado: (2020) -
Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial
por: Farnoosh, Gholamreza, et al.
Publicado: (2022) -
Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses
por: Zarezadeh Mehrabadi, Ali, et al.
Publicado: (2022) -
The effects of functional foods mixture on inflammatory cytokines and biochemical findings in hospitalized patients with COVID-19: a randomized double-blind controlled trial
por: Gouvarchinghaleh, Hadi Esmaeili, et al.
Publicado: (2023)